Skip to main content
Log in

Ethical dilemmas in hospice and palliative care

  • Review Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

In order to understand some of the ethical dilemmas that face hospice programs in the United States, one must understand the Medicare Hospice Benefit, which is the model by which hospice programs provide palliative care to terminally ill patients in the United States. Unlike palliative care programs outside the United States, patients must have a prognosis of 6 months or less to receive hospice care under the Medicare Hospice Benefit. Care is reimbursed on a per diem basis, and inpatient care is restricted to pain and symptom management that cannot be managed in another setting. Ethical dilemmas that face physicians referring patients to hospice programs include the ability of clinicians to predict accurately a patient prognosis of 6 months or less, and to what extent hospice programs and clinicians are obligated to provide patients with full information about their illness, as the Medicare Hospice Benefit requires that patients sign an informed consent in order to elect the hospice benefit. There are ethical dilemmas that affect day-to-day patient management in palliative care programs including physician concern over the use of morphine because of possible respiratory depression in the advanced cancer patient, the question of providing enteral or parenteral nutritional support to patients who refuse to eat near the end of life, and the question of providing parenteral fluids to patients who are unable to take fluids during the terminal phases of illness. A final ethical dilemma concerns the methodology for quality of life research in palliative care. By following current research dogma, and only considering patient-generated data as valid, the patient population that most needs to be studied is excluded. A new methodology specifically for palliative care research is needed to provide information on the patients who are cognitively or physically impaired and unable to provide input regarding their needs near the end of life.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Addington-Hall JM, MacDonald LD, Anderson HR (1990) Can the Spitzer quality of life index help to reduce prognostic uncertainty in terminal care? Br J Cancer 62:695–699

    Google Scholar 

  2. American College of Physicians (1989) Parenteral nutrition in patients receiving cancer chemotherapy. Ann Intern Med 110:734

    Google Scholar 

  3. American College of Physicians (1990) Harm is net result of TPN in cancer. Pharmacy Pract News, January

  4. Apilanez RV, Gonzalez de Langarica LR, Arribas EG (1987) Terminal illness syndrome. In: Fourth European Conference on Clinical Oncology and Cancer Nursing, Madrid, Federation of European Cancer Societies, p 193

  5. Baines M (1988) Nausea and vomiting in the patient with advanced cancer. J Pain Symptom Manage 3:81–85

    Google Scholar 

  6. Bayer R, Feldman E (1982) Hospice under the medicare wing. Hastings Cent Rep 12:5–6

    Google Scholar 

  7. Billings JA (1985) Comfort measures for the terminally ill. Is dehydration painful? J Am Geriatr Soc 33:808–810

    Google Scholar 

  8. Brennan MF (1981) Total parenteral nutrition in the management of the cancer patient. Annu Rev Med 32:233–243

    Google Scholar 

  9. Brescia FJ (1993) Specialized care of the terminally ill. In: DeVita VT, Hellman S, Rosenberg SA (eds) Cancer, principles and practice of oncology, 4th edn. Lippincott, Philadelphia, pp 2501–2508

    Google Scholar 

  10. Brescia FJ, Adler D, Gray G, et al (1990) Hospitalized advanced cancer patients: a profile. J Pain Symptom Manage 5:221–227

    Google Scholar 

  11. Brody H, Lynn J (1984) The physician's responsibility under the new Medicare reimbursement for hospice care. N Engl J Med 310:920–921

    Google Scholar 

  12. Bruera E (1990) Ambulatory infusion devices in the continuing care of patients with advanced diseases. J Pain Symptom Manage 5:287–296

    Google Scholar 

  13. Bruera E, MacDonald RN (1988) Nutrition in cancer patients: an update and review of our experience. J Pain Symptom Manage 3:133–140

    Google Scholar 

  14. Bruera E, Roca E, Cedaro L, et al (1985) Action of oral methylprednisolone in terminal cancer patients. Cancer Treat Rep 69:751–754

    Google Scholar 

  15. Bruera E, Macmillan K, Kuehn N, et al (1990) A controlled trial of megestrol acetate on appetite, caloric intake, nutritional status, and other symptoms in patients with advanced cancer. Cancer 66:1279–1282

    Google Scholar 

  16. Bruera E, Macmillan K, Pither J, MacDonald RN (1990) Effects of morphine on the dyspnea of terminal cancer patients. J Pain Symptom Manage 5:341–344

    Google Scholar 

  17. Bruera E, MacEachern T, Ripamonti C, Hanson J (1993) Subcutaneous morphine for dyspnea in cancer patients. Ann Intern Med 119:906–907

    Google Scholar 

  18. Burge FI (1993) Dehydration symptoms of palliative care cancer patients. J Pain Symptom Manage 8:454–464

    Google Scholar 

  19. Burge FI, King DB, Willison D (1990) Intravenous fluids and the hospitalized dying: a medical last rite? Can Fam Physician 36:883–886

    Google Scholar 

  20. Burt ME, Gorschboth CM, Brennan MF (1982) A controlled prospective randomized trial evaluating the metabolic effects of enteral and parenteral nutrition in the cancer patient. Cancer 49:1092–1105

    Google Scholar 

  21. Byrne P, Dunstan GR, Jakobovits I (1991) Hospice care: Jewish reservations considered in a comparative ethical study. Palliat Med 5:187–200

    Google Scholar 

  22. Campbell-Taylor I, Fisher RH (1987) The clinical case against tube feeding in palliative care in the elderly. J Am Geriatr Soc 35:1100–1104

    Google Scholar 

  23. Casseleith BR, Lusk EJ, Miller DJ, et al (1985) Psychosocial correlates of survival in advanced malignant diseases. N Engl J Med 312:1551–1555

    Google Scholar 

  24. Centeno-Cortes C (1994) Questioning diagnosis disclosure in terminal cancer patients: a prospective study evaluating patients' responses. Palliat Med 8:39–44

    Google Scholar 

  25. Ciocon JO, Silverstone FA, Graver LM, Foley CJ (1988) Tube feedings in elderly patients. Indications, benefits, and complications. Arch Intern Med 148:429–433

    Google Scholar 

  26. Collaud T, Rapin CH (1991) Dehydration in dying patients: study with physicians in French-speaking Switzerland. J Pain Symptom Manage 6:230–240

    Google Scholar 

  27. Corless IB (1983) The hospice movement in North America. In: Corr CA, Coor DM (eds) Hospice care, principles and practice. Springer, Berlin Heidelberg New York, pp 335–351

    Google Scholar 

  28. Cowcher K, Hanks GW (1990) Longterm management of respiratory symptoms in advanced cancer. J Pain Symptom Manage 5:320–330

    Google Scholar 

  29. Demer C, Johnston-Anderson AV, Tobin R, et al (1992) Cost of hospice care: late versus early entry (abstract). Proc Am Soc Clin Oncol 11:392

    Google Scholar 

  30. Dunn SM, Patterson PU, Butow PN, et al (1993) Cancer by another name: a randomized trial of the effects of euphemism and uncertainly in communicating with cancer patients. J Clin Oncol 11:989–996

    Google Scholar 

  31. Emanuel EJ, Emanuel LL (1994) The economics of dying. The illusion of cost savings at the end of life. N Engl J Med 330:540–544

    Google Scholar 

  32. Ettinger AB, Portenoy RK (1988) The use of corticosteroids in the treatment of symptoms associated with cancer. J Pain Symtom Manage 3:99–103

    Google Scholar 

  33. Evans C, McCarthy, M (1985) Prognostic uncertainty in terminal care: can the Karnofsky Index help? Lancet 1:1204–1206

    Google Scholar 

  34. Evans WK, Nixon DW, Daly JM, et al (1987) A randomized study of oral nutrition support versus ad lib nutritional intake during chemotherapy for advanced colorectal and non-small-cell lung cancer. J Clin Oncol 5:113–124

    Google Scholar 

  35. Farr WC (1990) The use of corticos-steroids for symptom management in terminally ill patients. Am J Hospice Care 7:41–46

    Google Scholar 

  36. Forster LE, Lynn J (1988) Predicting life span for applicants to inpatient hospice. Arch Intern Med 148:2540–2543

    Google Scholar 

  37. Forster LE, Lynn J (1989) The use of physiologic measures and demographic variables to predict longevity among inpatient hospice applicants. Am J Hospice Care 6:31–34

    Google Scholar 

  38. Forty-two Code of Federal Regulations (1993) Part 418. Medicare Hospice Regulations

  39. Hanks GE, Myers CE, Scardino PT (1993) Cancer of the prostate. In: DeVita VT Jr, Hellman S, Rosenberg SA (eds) Cancer: principles and practice of oncology, 4th edn. Lippincott, Philadelphia, pp 1073–1113

    Google Scholar 

  40. Harris JR, Morrow M, Bonadonna G (1993) Cancer of the breast. In: DeVita VT Jr, Hellman S, Rosenberg SA (eds) Cancer: principles and practice of oncology, 4th edn. Lippincott, Philadelphia, pp 1264–1332

    Google Scholar 

  41. Heber D, Byerley LO, Chi J, et al (1986) Pathophysiology of malnutrition in the adult cancer patient. Cancer 58:1867–1873

    Google Scholar 

  42. Kane RL, Wales J, Bernstein L, et al (1984) A randomised controlled trial of hospice care. Lancet I:890–894

    Google Scholar 

  43. Kaye P (1990) Notes on symptom control in hospice and palliative care. Hospice Education Institute, Essex, Conn, pp 27–29

    Google Scholar 

  44. Kidder D (1988) The impact of hospice on the health care costs of terminal cancer patients. In: Mor V, Greer D, Kastenbaum R (eds) The hospice experiment. Johns Hopkins, Baltimore, pp 48–68

    Google Scholar 

  45. Kidder D (1992) The effects of hospice coverage on Medicare expenditures. Health Serv Res 27:195–217

    Google Scholar 

  46. Kinzbrunner BM (1994) Hospice: what to do when anti-cancer therapy is no longer appropriate, effective, or desired. Semin Oncol (in press)

  47. Klein S (1993) Clinical efficacy of nutritional support in patients with cancer. Oncology 7 [Suppl]:87–92

    Google Scholar 

  48. Klein S, Simes J, Blackburn GL (1986) Total parenteral nutrition and cancer clinical trials. Cancer 58:1378–1386

    Google Scholar 

  49. Koretz RL (1984) Parenteral nutrition: is it oncologically logical? J Clin Oncol 2:534–538

    Google Scholar 

  50. Lack S (1983) The hospice concept — the adult with advanced cancer. In: Corr CA, Coor DM (eds) Hospice care, principles and practice. Springer, Berlin Heidelberg New York, pp 42–54

    Google Scholar 

  51. Levy MH, Catalano RB (1985) Control of common physical symptoms other than pain in patients with terminal disease. Semin Oncol 12:411–430

    Google Scholar 

  52. Light RW, Muro JR, Sato RI, et al (1989) Effects of oral morphine on breathlessness and exercise tolerance in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 139:126–133

    Google Scholar 

  53. Loprinzi CL (1993) Pharmacologic management of cancer anorexia/cachexia. Oncology 7 [Suppl]:101–103

    Google Scholar 

  54. Loprinzi C Ellison NM, Schaid DJ, et al (1990) Controlled trial of megestrol acetate for the treatment of cancer anorexia and cachexia. J Natl Cancer Inst 82:1127–1132

    Google Scholar 

  55. Loprinzi CL, Goldberg RG, Su JQ, et al (1993) Randomized double-blind placebo controlled trial evaluating hydrazine sulfate in patients with newly diagnosed non-small cell lung cancer (abstract). Proc Am Soc Clin Oncol 12:337

    Google Scholar 

  56. Loprinzi CL, Michalak JC, Schaid DJ, et al (1993) Phase III evaluation of four doses of megestrol acetate therapy for patients with cancer anorexia and/or cachexia. J Clin Oncol 11:762–767

    Google Scholar 

  57. Lubitz JD, Riley GF (1993) Trends in Medicare payments in the last year of life. N Engl J Med 328:1092–1096

    Google Scholar 

  58. McCullough LB (1992) A primer on bioethics. In: McCullough LB, Bauer J, Kindig D, Schenke R (eds) Review course for the ABMM examination. American College of Physician Executives, Boston, pp 1–20

    Google Scholar 

  59. McCusker J (1984) The terminal period of cancer: definition and descriptive epidemiology. J Chronic Dis 37:377–385

    Google Scholar 

  60. Micetich KC, Steinecker PH, Thomasma DC (1983) Are intravenous fluids morally required for a dying patient? Arch Intern Med 143:975–978

    Google Scholar 

  61. Miller RJ (1991) Predicting survival in the advanced cancer patient. Henry Ford Hosp Med J 39:81–83

    Google Scholar 

  62. Mor V (1987) The cost of hospice. In: Mor V (ed) Hospice care systems, structure, process costs, and outcomes. Springer, Berlin Heidelberg New York, pp 177–212

    Google Scholar 

  63. Mor V (1987) Quality of life outcomes. In: Mor V (ed) Hospice care systems, structure, process, costs, and outcomes. Springer, Berlin Heidelberg New York, pp 125–176

    Google Scholar 

  64. Mor V, Masterson-Allen S (1990) A comparison of hospice vs conventional care of the terminally ill cancer patient. Oncology 4:85–91

    Google Scholar 

  65. Mor V, Laliberte L, Morris JN, et al (1984) The Karnofsky Performance Status Scale, an examination of its reliability and validity in a research setting. Cancer 53:2002–2007

    Google Scholar 

  66. Mor V, Greer DS, Goldberg R (1988) The medical and social service interventions of hospice and nonhospice patients. In: Mor V, Greer D, Kastenbaum R (eds) The hospice experiment. Johns Hopkins, Baltimore, pp 88–108

    Google Scholar 

  67. Morris JN, Sherwood S, Wright SM, Gutkin CE (1988) The last weeks of life: does hospice care make a difference? In: Mor V, Greer D, Kastenbaum R (eds) The hospice experiment. Johns Hopkins, Baltimore, pp 109–132

    Google Scholar 

  68. Mullen JL (1981) Complications of total parenteral nutrition in the cancer patient. Cancer Treat Rep 65 [Suppl 5]:107–113

    Google Scholar 

  69. Needs and responses — the hospice approach (1983) In: Corr CA, Coor DM (eds) Hospice care, principles and practice. Springer, Berlin Heidelberg New York, pp 1–4

    Google Scholar 

  70. Nelson KA, Walsh TD (1993) Metoclopramide in anorexia caused by cancer-associated dyspepsia syndrome (CADS). J Palliat Care 9:14–18

    Google Scholar 

  71. Nelson KA, Walsh D, Sheehan FA (1994) The cancer anorexia-cachexia syndrome. J Clin Oncol 12:213–225

    Google Scholar 

  72. NHO Newsline (1993) 1992 stats show continued growth in programs and patients. NHO Newsline 3:1–2

    Google Scholar 

  73. Nixon DW (1986) The value of parenteral nutrition support. Chemotherapy and radiation treatment. Cancer 58:1902–1903

    Google Scholar 

  74. Oliver D (1993) Ethical issues in palliative care — an overview. Palliat Med 7 [Suppl 2]:15–20

    Google Scholar 

  75. Ovesen L, Allingstrup L, Hannibal J, et al (1993) Effect of dietary counseling on food intake, body weight, response rate, survival, and quality of life in cancer patients undergoing chemotherapy: a prospective, randomized study. J Clin Oncol 11:2043–2049

    Google Scholar 

  76. Parkes CM (1972) Accuracy of predictions of survival in later stages of cancer. Br Med J II:29–31

    Google Scholar 

  77. Phillips PA, Rolls BJ, Ledingham JGG, et al (1984) Reduced thirst after water deprivation in healthy elderly men. N Engl J Med 311:753–759

    Google Scholar 

  78. Portenoy RK, Coyle N (1990) Controversies in the long-term management of analgesic therapy in patients with advanced cancer. J Pain Symptom Manage 5:307–319

    Google Scholar 

  79. Printz LA (1988) Is withholding hydration a valid comfort measure in the terminally ill? Geriatrics 43:85–88

    Google Scholar 

  80. Reuben DB, Mor V (1986) Dyspnea in terminally ill cancer patients. Chest 89:234–236

    Google Scholar 

  81. Reuben DB, Mor V, Hiris J (1988) Clinical symptoms and length of survival in patients with terminal cancer. Arch Intern Med 148:1586–1591

    Google Scholar 

  82. Rhymes J (1990) Hospice care in America. JAMA 264:369–372

    Google Scholar 

  83. Rogers DF, Barnes PG (1989) Opioid inhibition of neurally mediated mucous secretion in human bronchi. Lancet I:930–931

    Google Scholar 

  84. Rosenthal MA, Gebski VJ, Kefford RF, et al (1993) Prediction of life-expectancy in hospice patients: identification of novel prognostic factors. Palliat Med 7:199–204

    Google Scholar 

  85. Rousseau PC (1991) How fluid deprivation affects the terminally ill. RN, January, pp 73–76

  86. Santiago TV, Edelman NH (1985) Opioids and breathing. J Appl Physiol 59:1675–1685

    Google Scholar 

  87. Saunders CM (1983) The last stages of life. In: Corr CA, Coor DM (eds) Hospice care, principles and practice. Springer, Berlin Heidelberg New York, pp 5–11

    Google Scholar 

  88. Schonwetter RS, Teasdale TA, Storey P, Luchi RJ (1990) Estimation of survival time in terminal cancer patients: an impedance to hospice admissions? Hospice J 6:65–79

    Google Scholar 

  89. Scott AG (1994) Nasogastric feeding in the management of severe dysphagia in motor neurone disease. Palliat Med 8:45–49

    Google Scholar 

  90. Smith DH, Granbois JA (1982) The American way of hospice. Hastings Cent Rep 11:8–10

    Google Scholar 

  91. Souba WW, Copeland EM (1989) Hyperalimentation in cancer. CA Cancer J Clin 39:105–113

    Google Scholar 

  92. Stuart SP, Tiley EH, Boland JP (1993) Feeding gastrostomy: a critical review of its indications and mortality rate. South Med J 86:169–172

    Google Scholar 

  93. Tchekmedyian NS, Hickman M, Siau J, et al (1990) Treatment of cancer anorexia with megestrol acetate: impact on quality of life. Oncology 4:184–192

    Google Scholar 

  94. Von Roenn JH, Cleeland CS, Gonin R, et al (1993) Physician attitudes and practice in cancer pain management. A survey from the Eastern Cooperative Oncology group. Ann Intern Med 119:121–126

    Google Scholar 

  95. Wallston KA, Burger C, Smith RA, Baugher RJ (1988) Comparing the quality of death for hospice and nonhospice cancer patients. Med Care 26:177–182

    Google Scholar 

  96. Woodcock AA, Gross ER, Gellert A, et al (1981) Effects of dihydrocodeine, alcohol, and caffeine on breathlessness and exercise tolerance in patients with chronic obstructive lung disease and normal blood gases. N Engl J Med 305:1611–1616

    Google Scholar 

  97. Yates JW, Chalmer B, McKegney FP (1980) Evaluation of patients with advanced cancer using the Karnofsky performance status. Cancer 45:2220–2224

    Google Scholar 

  98. Ziegler TR, Young LS, Benfell K, et al (1992) Clinical and metabolic efficacy of glutamine-supplemented parenteral nutrition after bone marrow transplantation. Ann Intern Med 116:821–828

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kinzbrunner, B.M. Ethical dilemmas in hospice and palliative care. Support Care Cancer 3, 28–36 (1995). https://doi.org/10.1007/BF00343918

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00343918

Key words

Navigation